Learning Objective #1: list patient characteristics that predict depression in type 2 diabetes. | |||
Learning Objective #2: justify the importance of assessing depression in type 2 diabetes. |
Objective: This study was conducted using the biopsychosocial model to examine whether demographic characteristics and diabetes-related co-morbidities predict depression in type 2 diabetes?
Design: Cross sectional survey
Population, Sample, Setting: Type 2 diabetics (N=55) aged ³35 years, 42% female, 36% African American were recruited by convenience sample from an inner city Joslin diabetes clinic.
Variables: Dependent: depression: Independent: demographics, diabetes-related macro (coronary artery disease, hyperlipidemia, hypertension, obesity) and micro (nephropathy, neuropathy and retinopathy) co-morbidities
Methods: After informed consent patients completed Beck Depression Inventory-II (BDI, depression) and demographic questionnaires. Complications, height and weight were obtained from the medical record.
Findings: 41% were depressed (BDI >13); 27% moderately or severely depressed (BDI³20). All patients had at least 1 diabetes-related co-morbidity; 58% had ³1 micro co-morbidity; 64% had 2-3 macro co-morbidities. Lower age [β=-.388, t=-3.050, p=.004] and being female [β=.300, t=2.359, p=.023] were significant independent predictors of depression score (R2=16.4). Race and interactions of age, gender and race did not add to the prediction. Neuropathy [F(1,45)=3.492, p=.068] tended to add to the prediction of depression score beyond age and gender; other co-morbidities did not . Further examination revealed that both lower age [β=-.502, t=-3.876, p<.001] and neuropathy [β=.344, t=2.654, p=.011] were independent predictors of depression score (R2=24.9%); gender was not.
Conclusion: In type 2 diabetics younger age and neuropathy predicted depression. Clinicians need to assess depression in type 2 diabetics especially younger patients and those with signs of neuropathy.